Actively Recruiting
A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
Led by Guangdong Provincial People's Hospital · Updated on 2020-01-13
50000
Participants Needed
2
Research Sites
1617 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.
CONDITIONS
Official Title
A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Diagnosed with hypertension, defined by blood pressure 140/90 mmHg or higher, use of antihypertensive drugs, or self-reported hypertension
- Provided written informed consent
You will not qualify if you...
- Under 18 years old
- Have not signed informed consent
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080
Actively Recruiting
2
Guangdong Cardiovascular Institute
Guangzhou, Guangdong, China, 510100
Actively Recruiting
Research Team
F
Feng Ying-qing, PhD
CONTACT
H
HUANG Yu qing, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here